Anticoagulation therapy, IDH1 mutation, MGMT methylation, radiotherapy, chemotherapy, and prolonged bed rest can reduce the risk of VTE, while larger tumor volume, grade 4 glioma, EGFR positivity, p53 mutation, glucocorticoid therapy and CVCP increase the risk of VTE. The gene discussed is IDH1; the disease is central nervous system cancer.